Publications by authors named "Dirk Debus"

Claim this Profile
P
Personalized therapies in advanced BRAFV600-mutated melanoma: review based on 3 case reports of the REMINISCENCE project.
Christoffer Gebhardt, Dirk Debus, Peter Rohrer, Katharina C Kähler, Lukas Koch

Melanoma Manag· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-specific survival in advanced metastatic melanoma - a DeCOG study on 2032 patients of the multicenter prospective skin cancer registry ADOREG.
Anna-Sophia Leven, Triinu Peters, Luisa Sophie Rajcsanyi, Michael Weichenthal, Peter Mohr, Dirk Debus

Eur J Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Adjuvant and neoadjuvant therapy of melanoma].
Dirk Debus, Axel Hauschild, Erwin S Schultz

Dtsch Med Wochenschr· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness, safety and utilization of cobimetinib and vemurafenib in patients with BRAF V600 mutant melanoma with and without cerebral metastasis under real-world conditions in Germany: the non-interventional study coveNIS.
Katharina C Kähler, Dirk Debus, Gaston Schley, Daniela Göppner, Jessica C Hassel

Melanoma Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment management for -mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG.
Maximilian Haist, Henner Stege, Friederike Rogall, Yuqi Tan, Imke von Wasielewski, Dirk Debus

J Immunother Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COMBI-r: A Prospective, Non-Interventional Study of Dabrafenib Plus Trametinib in Unselected Patients with Unresectable or Metastatic BRAF V600-Mutant Melanoma.
Carola Berking, Elisabeth Livingstone, Dirk Debus, Carmen Loquai, Michael Weichenthal

Cancers (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes using PD-1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland.
Katharina Schumann, Cornelia Mauch, Kai-Christian Klespe, Carmen Loquai, Ulrike Nikfarjam, Dirk Debus

J Eur Acad Dermatol Venereol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG.
Cindy Franklin, Peter Mohr, Leonie Bluhm, Friedegund Meier, Marlene Garzarolli, Dirk Debus

J Immunother Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG.
Cindy Franklin, Peter Mohr, Leonie Bluhm, Imke Grimmelmann, Ralf Gutzmer, Dirk Debus

J Immunother Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma - An evaluation of the multicenter prospective skin cancer registry ADOREG.
Sophia Kreft, Valerie Glutsch, Anne Zaremba, Patrick Schummer, Peter Mohr, Dirk Debus

Eur J Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Local Treatment of a Leishmania tropica Infection in a Syrian Child with a Novel Filmogenic Preparation of Pharmaceutical Sodium Chlorite (LeiProtect®).
Dirk Debus, Semra Genç, Philipp Kurz, Martin Holzer, Kurt Bauer, Andrea Debus

Am J Trop Med Hyg· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG).
Theresa Steeb, Anja Wessely, Mareike Alter, Christiane Bayerl, Armin Bender, Dirk Debus

J Cancer Res Clin Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipase elevation and type 1 diabetes mellitus related to immune checkpoint inhibitor therapy - A multicentre study of 90 patients from the German Dermatooncology Group.
Imke Grimmelmann, Michael Momma, Lisa Zimmer, Jessica C Hassel, Lucie Heinzerling, Dirk Debus

Eur J Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma-A Retrospective Multicenter ADOReg Study.
Henner Stege, Maximilian Haist, Michael Schultheis, Maria Isabel Fleischer, Peter Mohr, Dirk Debus

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with BRAF-Mutant Advanced/Metastatic Melanoma: Original Research on the Treatment Reality in Germany and Austria in the Era of Choice.
Sebastian Haferkamp, Mareike Alter, Dirk Debus, Bastian Schilling, Andreas Pinter

Adv Ther· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients.
Teresa Amaral, Felix Kiecker, Sarah Schaefer, Henner Stege, Katharina Kaehler, Dirk Debus

J Immunother Cancer· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 blockade in patients with advanced cutaneous squamous-cell carcinoma and concurrent chronic lymphocytic leukaemia : a case series and literature review.
Julia Eglmeier, Dirk Debus, Erwin S Schultz

Eur J Dermatol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Malignant melanoma - from diagnosis to follow-up care].
Manuel Krieter, Erwin Schultz, Dirk Debus

MMW Fortschr Med· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases.
Ricarda Rauschenberg, Johannes Bruns, Julia Brütting, Dirk Daubner, Fabian Lohaus, Dirk Debus

Eur J Cancer· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intermittent vemurafenib therapy in malignant melanoma.
Nicolai Treiber, Margit Anna Huber, Lars Alexander Schneider, Karin Scharffetter-Kochanek, Erwin Schultz, Dirk Debus

J Dtsch Dermatol Ges· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intervalltherapie mit Vemurafenib beim malignen Melanom.
Nicolai Treiber, Margit Anna Huber, Lars Alexander Schneider, Karin Scharffetter-Kochanek, Erwin Schultz, Dirk Debus

J Dtsch Dermatol Ges· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Afatinib-associated Stevens-Johnson syndrome in an EGFR-mutated lung cancer patient.
Janine Doesch, Dirk Debus, Christian Meyer, Thomas Papadopoulos, Erwin S Schultz

Lung Cancer· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab exerts a dual effect in pemphigus vulgaris.
Rüdiger Eming, Angela Nagel, Sonja Wolff-Franke, Eva Podstawa, Dirk Debus

J Invest Dermatol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis